Purpose: Infantile Marfan syndrome (MFS) is a rare congenital inheritable connective tissue disorder with poor prognosis. This study aimed to evaluate the cardiovascular manifestations and overall prognosis of infantile MFS diagnosed in a tertiary referral center in Korea.

Methods: Eight patients diagnosed with infantile MFS between 2004 and 2014 were retrospectively evaluated.

Results: Their median age at the time of diagnosis was 2.5 months (range, 0-20 months). The median follow-up period was 25.5 months (range, 0-94 months). The median length at birth was 50.0 cm (range, 48-53 cm); however, height became more prominent over time, and the patients were taller than the 97th percentile at the time of the study. None of the patients had any relevant family history. Four of the 5 patients who underwent DNA sequencing had a fibrillin 1 gene mutation. All the patients with echocardiographic data of the aortic root had a z score of >2. All had mitral and tricuspid valve prolapse, and various degrees of mitral and tricuspid regurgitation. Five patients underwent open-heart surgery, including mitral valve replacement, of whom two required multiple operations. The median age at mitral valve replacement was 28.5 months (range, 5-69 months). Seven patients showed congestive heart failure before surgery or during follow-up, and required multiple anti-heart failure medications. Four patients died of heart failure at a median age of 12 months.

Conclusion: The prognosis of infantile MFS is poor; thus, early diagnosis and timely cautious treatment are essential to prevent further morbidity and mortality.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4781733PMC
http://dx.doi.org/10.3345/kjp.2016.59.2.59DOI Listing

Publication Analysis

Top Keywords

infantile mfs
12
median age
12
months range
12
infantile marfan
8
marfan syndrome
8
tertiary referral
8
referral center
8
prognosis infantile
8
patients
8
months median
8

Similar Publications

Article Synopsis
  • Biochemical recurrence (BCR) in prostate cancer presents variability, necessitating a risk stratification to differentiate low- and high-risk cases for progression.
  • Current methods, particularly PSA doubling time (PSA-DT), help classify BCR cases, while the use of advanced imaging like PSMA PET/CT is important for identifying metastases before deciding on treatment.
  • Low-risk BCR patients should be monitored without immediate systemic therapy, while high-risk patients benefit from early intervention with treatments like enzalutamide combined with leuprolide, which has shown to improve metastasis-free survival without compromising quality of life.
View Article and Find Full Text PDF

Background: Gene expression profiling (GEP) studies recognized a prognostic role for tumor microenvironment (TME) in diffuse large B-cell lymphoma (DLBCL), but the routinely adoption of prognostic stromal signatures remains limited.

Patients And Methods: Here, we applied the computational method CIBERSORT to generate a 1028-gene matrix incorporating signatures of 17 immune and stromal cytotypes. Then, we carried out a deconvolution on publicly available GEP data of 482 untreated DLBCLs to reveal associations between clinical outcomes and proportions of putative tumor-infiltrating cell types.

View Article and Find Full Text PDF

Objective: Infantile-onset spinal muscular atrophy (SMA) is the most common genetic cause of infant mortality, typically resulting in death preceding age 2. Clinical trials in this population require an understanding of disease progression and identification of meaningful biomarkers to hasten therapeutic development and predict outcomes.

Methods: A longitudinal, multicenter, prospective natural history study enrolled 26 SMA infants and 27 control infants aged <6 months.

View Article and Find Full Text PDF

Myofibromatosis (MFS) was recognized as a distinct form of childhood fibromatosis. Infantile myofibromatosis (IMF) is now identified as a solitary or multicentric tumor that predominantly occurs in neonates and infants. The adult counterpart of IMF, though of rare occurrence, is identified and is known as MFS.

View Article and Find Full Text PDF

Recurrent Somatic PDGFRB Mutations in Sporadic Infantile/Solitary Adult Myofibromas But Not in Angioleiomyomas and Myopericytomas.

Am J Surg Pathol

February 2017

*Institute of Pathology ¶Department of Paediatrics, University Hospital, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen †Division of Theoretical Bioinformatics (B080) #Division Molecular Genome Analysis **Genomics & Proteomics Core Facility, German Cancer Research Center (DKFZ), Heidelberg §Institute of Pathology, St. Vincent's Hospital, Karlsruhe ∥Institute of Pathology, Klinikum Augsburg, Augsburg ‡‡Dermatopathologische Gemeinschaftspraxis, Friedrichshafen, Germany ‡Department of Pathology, Faculty of Medicine in Plzen and Charles University Hospital, Biomedical Center ††Department of Pathology, Faculty of Medicine, Charles University, Plzen, Czech Republic.

Infantile myofibroma (MF) is an uncommon benign myofibroblastic tumor of infancy and childhood. Solitary adult MF shares similar features with infantile MF. The lesions occur in 3 clinicopathologic settings: solitary, multicentric, and generalized and can be either sporadic or familial.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!